In addition, survival analysis indicated that changes in the expression of ACTA2, COL3A1, TPM1, ACTC1, and ACTN1 were associated with a poor prognosis of BC, while PPARG overexpression indicated a better OS outcome. The gene discussed is ACTA2; the disease is breast cancer.